Diabetes Drugs - Part 1 Flashcards

1
Q

Diabetes Mellitus:

A

insufficiency of insulin signaling relative to the req’s of the tissues for this hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diabetes Mellitus sx’s?

A

polyuria, polydipsia, polyphagia

elevated fasting blood sugar, ketosis, weight loss etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fasting plasma glucose DM level

A

> / 7.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Plasma glucose 2 hours after 75-g glucose load

A

> / 11.1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T1D

A

10-20%, (Insulin – Dependent Diabetes Mellitus, IDDM; Juvenile onset diabetes). Autoimmune destruction of beta cells of pancreas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T2D

A

10-20%, (Insulin – Dependent Diabetes Mellitus, IDDM; Juvenile onset diabetes). Autoimmune destruction of beta cells of pancreas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Insulin secretion from the b cells of the pancreas

A

Resting state (low glucose prior to meal): GLUT2 is a equilibritor transporter b/c driven by [ ] of glucose
- if increased glc outside, glc will enter cell & it’ll equilibrate the [ ]
- ratio of ATP/ADP stays low & Katp channel opens due to hyperpolarization
- VG Ca channel closed & no insulin released

Glucose-stimulated state:
- Post meal (high glc)
- Picked up by metabolism machinery & metabolize glc to increase ATP/ADP ratio
- Katp channel closes & depolarization of mem. & therefore opens Ca channels
- Ca increases & stimulation insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Increased glucose uptake (GLUT4) - insulin dependent glucose transporter - controls insulin dependent reuptake

A
  • skeletal muscle
  • cardiac muscle
  • smooth muscle
  • liver
  • adipose tissue
  • leucocytes
  • pituitary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

No effect glucose (GLUT 1/2) 0 equilibrium forms if increased glc outside cell, you’ll see movement of glucose inside the cell (independent of insulin)

A
  • brain
  • kidney
  • intestinal mucosa
  • RBC
  • endothelium
  • pancreas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the insulin actions?

A
  • insulin increase glycogen production
    – glc is converted & stored as glycogen
  • this also inhibits gluconeogenesis (break down of glycogen) to free up glucose
  • increase TG storage (esp. in adipose tissue) & throughout tissues it increases protein syn.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Defects in glucose levels in diabetes:

A

Increase in EXTRACELLULAR glucose
- result of loss of insulin & insulin sensitivity

Decrease in INTRACELLULAR glucose (in tissues with insulin-sensitive glucose transporters)
- skeletal muscle is starved of glucose (why you get muscle wasting in diabetes)

Increase in INTRACELLULAR glucose (in tissues with non-insulin sensitive transporters)
- in tissue (brain, endothelial cells etc. b/c they primarily express GLUT2 or GLUT2, increase external glc –> increase intracellular glucose (toxic to the cell; what drives diabetic complications in multiple organ systems)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How insulin can control insulin dep. glucose uptake (GLUT4) in skeletal muscle for ex

A
  1. Insulin triggers association of IRS 1 & 2
  2. => activation of P13kinase which phosphorylates Akt/PKb
  3. Interacts directly w/ GLUT4 & moves it to the membrane where it can allow glucose entry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Insulin & glucagon are ______ after a meal

A

antagonistic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

_____ is central for controlling the BG levels & this goes wrong in T2D pts

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In T2D the _____ is dysfunctional => increased glucose production contributing to hypoglycaemia => T2D

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complications of diabetes:

A
  • Coma (serious situation)
  • BV’s (angiopathy)
  • Eyes (retinopathy)
  • Kidneys (nephropathy)
  • Nerves (neuropathy)
17
Q

What are the 3 forms in the insulin synthesis pathway?

A
  1. Pre-proinsulin
  2. Proinsulin
  3. Insulin

Chain C is the segment of peptide cleaved

18
Q

Insulin LISPRO & ASPART:

A

Onset: 10-30 min
Peak: 0.5-3
Duration: 3-5

RAPID-ACTING

19
Q

Regular NOVOLIN R:

A

Onset: 0.5-1
Peak: 2-5
Duration: 4-12

SHORT-ACTING

20
Q

NPH/Humulin N:

A

Onset: 1-2
Peak: 4-8
Duration: 10-20

INTERMEDIATE

21
Q

NPH/Regular:

A

Onset: 0.5-1
Peak: 2-12
Duration: 18-24

LONG-ACTING

22
Q

Insulin Glargine:

A

Onset: 1-4
Peak: no peak
Duration: 22-24

LONG-ACTING

23
Q

Insulin Detemir:

A

Onset: 1-4
Peak: flat
Duration: 12-20

LONG-ACTING

24
Q

Insulin Lispro Characteristics:

A
  • Analog of human insulin in which amino acids #28 and #29 (lysine and proline) in the beta chain are reversed.
  • Pharmacokinetics differ from normal insulin
  • Reduces anti-parallel dimer formation
  • Monomer > dimer
  • Rapid absorption & shorter duration of action (similar to endogenous insulin)
  • More closely resembles insulin response to a meal
  • Insulin Aspart
25
Insulin Lispro Use:
- Should be taken 15 mins prior to a meal - Both TID & T2D pts can use Humalog - Total daily dose 0.5-1 U/kg
26
Insulin Lispro Benefits:
- Tighter control of glucose, no AE on HbA1c - Decreased incidents & risk of hypoglycemia
27
Regular Novolin R Characteristics:
- Recombinant insulin - Dimers form hexamers in the vial – stable - Delays absorption into blood stream – acts as a depot - Over time hexamers breakdown to release bioactive insulin monomers - Taken 30-45 min before a meal - 0.5-1.0 U/kg/day (maintenance dose) - Regular Humulin R
28
Insulin Glargine Characteristics:
- Human long acting insulin - Differs in 3 AA’s in beta chain - Aspargine replaced by glycine, 2 arginine added at C-terminus - Soluble & clear in pH 4 solution - Precipitates at neutral pH in subcutaneous tissue - One injection per day (but 2 in some cases) – 15-30 U - Slowly absorbed, duration of action 24 hours - No peak - Insulin Determir Less nocturnal hypoglycemia
29
Insulin Glargine AE's:
- Pain at the site of injection - Other potential effects (tumor growth) – remains to be established NB it cannot be diluted or mixed w/ any other insulins
30
New preps & technology:
1. Nasal sprays 2. Insulin inhalers 3. Insulin pumps
31
Hypoglycemic actions of insulin decreased by:
- Glucocorticoids - Glucagon - Epinephrine - Growth Hormone - Thyroid Hormone
32
Hypoglycemic actions of insulin increased by:
- ACE inhibitors - Alcohol - Salicylate - Beta blockers - MAO inhibitors (dangerous)
33
AE's of Insulin:
1. Hypoglycemia - hunger, sweating, blurred vision, headache, fatigue -- coma & death -- unawareness in the elderly due to insulin overdose, exercise, failure to eat, labile disease - treat w/ oral or IV glucose, sc glucagon 2. Lipoatrophy 3. Allergy